Abstract
Background: Gilles de la Tourette Syndrome (GTS) is a multifaceted neuropsychiatric developmental disorder with onset in childhood or adolescence and frequent remissions in early adulthood. A rather new emerging concept of this syndrome suggests that it is a disorder of purposeful actions, in which sensory processes and their relation to motor responses (actions) play a particularly important role. Thus, this syndrome might be conceived as a condition of altered ‘perception-action binding’. In the current study, we test this novel concept in the context of inhibitory control. Methods: We examined N = 35 adolescent GTS patients and N = 39 healthy controls in a Go/Nogo-task manipulating the complexity of sensory information triggering identical actions; i.e. to inhibit a motor response. This was combined with event-related potential recordings, EEG data decomposition and source localization. Results: GTS patients showed worse performance compared to controls and larger performance differences when inhibitory control had to be exerted using unimodal visual compared to bimodal auditory-visual stimuli. This suggests increased binding between bimodal stimuli and responses leading to increased costs of switching between responses instructed by bimodal and those instructed by unimodal stimuli. The neurophysiological data showed that this was related to mechanisms mediating between stimulus evaluation and response selection; i.e. perception-action binding processes in the right inferior parietal cortex (BA40). Conclusions: Stimulus-action inhibition binding is stronger in GTS patients than healthy controls and affects inhibitory control corroborating the concept suggesting that GTS might be a condition of altered perception-action integration (binding); i.e. a disorder of purposeful actions.
| Original language | English |
|---|---|
| Journal | Journal of Child Psychology and Psychiatry and Allied Disciplines |
| Volume | 60 |
| Issue number | 9 |
| Pages (from-to) | 953-962 |
| Number of pages | 10 |
| ISSN | 0021-9630 |
| DOIs | |
| Publication status | Published - 09.2019 |
Funding
This work was supported by Grants from the Deutsche Forschungsgemeinschaft (DFG) MU 1692/4-1, BE4045/19-1 and FOR 2698. V.R. has received payment for consulting and writing activities from Lilly, Novartis, and Shire Pharmaceuticals, lecture honoraria from Lilly, Novartis, Shire Pharmaceuticals, and Medice Pharma, and support for research from Shire and Novartis. He has carried out (and is currently carrying out) clinical trials in cooperation with the Novartis, Shire, and Otsuka companies. A.M. has received commercial research support and honoraria from Pharm Allergan, Ipsen, Merz Pharmaceuticals, Actelion, GlaxoSmithKline, Desitin and Teva. C.B. has received payment for consulting from GlaxoSmithKline, Novartis, Teva and Genzyme. The remaining authors have declared that they have no competing or potential conflicts of interest.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 10 Reduced Inequalities
Research Areas and Centers
- Research Area: Medical Genetics
DFG Research Classification Scheme
- 2.23-04 Cognitive, Systems and Behavioural Neurobiology
Fingerprint
Dive into the research topics of 'Altered perception-action binding modulates inhibitory control in Gilles de la Tourette syndrome'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver